Related Experiment Video

Updated: Apr 18, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.4K

Words of wisdom. Re: Antibody-drug conjugates targeting prostate-specific membrane antigen

Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng

    European Urology
    |January 15, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    11.9K
    Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
    11:58

    Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

    Published on: March 8, 2018

    8.1K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
    11:02

    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

    Published on: September 14, 2018

    8.4K
    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    11.9K
    Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
    11:58

    Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

    Published on: March 8, 2018

    8.1K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.2K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    Molecular pathology of urothelial carcinoma.

    Human pathology·2021

    Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.

    Translational andrology and urology·2021

    Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?

    Translational andrology and urology·2021

    TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.

    Translational andrology and urology·2021

    Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.

    Translational andrology and urology·2021

    Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

    Translational andrology and urology·2021

    Challenges of Using Circulating Tumour DNA: Insights from Advanced Prostate Cancer.

    European urology·2026

    Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform.

    European urology·2026

    Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

    European urology·2026

    In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells.

    bioRxiv : the preprint server for biology·2026

    Transdermal diagnosis and therapy using an integrated acoustofluidic patch.

    bioRxiv : the preprint server for biology·2026

    RNA trans-splicing treatment for Duchenne muscular dystrophy.

    bioRxiv : the preprint server for biology·2026

    Porous Polymeric Materials for Cell Delivery and Regenerative Therapy: Design Principles, AI-Assisted Optimization, and Clinical Translation.

    Advanced healthcare materials·2026

    Anatomical-molecular interaction in glioblastoma: subventricular zone involvement and MGMT-related survival benefit.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026

    Managing refractory herpes simplex keratitis.

    The British journal of ophthalmology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us